HUTCHMED (China) (HCM) Long-Term Investments (2014 - 2025)
HUTCHMED (China)'s (HCM) quarterly Long-Term Investments came in at $1.4 million in Q4 2025, down 86.03% year-on-year from $10.0 million in Q4 2024, and down 72.06% on a QoQ basis from $5.0 million in Q2 2025.
HUTCHMED (China) (HCM) Long-Term Investments (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 12 years of Long-Term Investments data on file, last reported at $1.4 million in Q4 2025.
- On a quarterly basis, Long-Term Investments fell 86.03% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 86.03% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 85.98% from the prior year.
- Long-Term Investments for Q4 2025 stood at $1.4 million, down from $5.0 million in the prior quarter.
- Over the last five years, Long-Term Investments for HCM reached as high as $6.2 billion in Q4 2023 and fell as low as $1.4 million in Q4 2025.
- Historically, Long-Term Investments has averaged $607.7 million across 5 years, with a median of $37.7 million in 2023.
- Across the five-year window, Long-Term Investments soared 65591.08% in 2023 and tumbled 99.84% in 2024, its largest moves.
- Year by year, Long-Term Investments stood at $9.8 million in 2021, then fell by 3.94% to $9.4 million in 2022, then surged by 65591.08% to $6.2 billion in 2023, then tumbled by 99.84% to $10.0 million in 2024, then tumbled by 86.03% to $1.4 million in 2025.
- Per Business Quant data, the three most recent Long-Term Investments figures were $1.4 million in Q4 2025, $5.0 million in Q2 2025, and $10.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.40 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Jun 30, 2024 | 80.52 Mn |
| Dec 31, 2023 | 6.20 Bn |
| Jun 30, 2023 | 37.74 Mn |
| Dec 31, 2022 | 9.43 Mn |
| Jun 30, 2022 | 83.00 Mn |
| Dec 31, 2021 | 9.82 Mn |
| Jun 30, 2021 | 118.32 Mn |
| Mar 31, 2021 | 133.82 Mn |
| Jun 30, 2020 | 106.97 Mn |
| Sep 30, 2019 | 145.34 Mn |
| Jun 30, 2019 | 146.98 Mn |
| Mar 31, 2019 | 158.93 Mn |
| Dec 31, 2018 | -8.00 Mn |
| Sep 30, 2018 | -8.00 Mn |
| Jun 30, 2018 | 161.59 Mn |
| Dec 31, 2017 | 7.00 Mn |
| Jun 30, 2017 | 147.82 Mn |